{"document": {"publication": "Tag My News", "full_text": "the u.s. drugs regulator said it was not recommending changes in the use of stimulants such as adderall xr and ritalin to treat hyperactivity, after a review of a study into potential heart disease risks from the drugs.", "title": "fda eases adhd drugs heart-disease concerns", "line_count": 1, "filename": "4811", "publication_date": "08-04-2011 12:39:01", "lines_and_colors": [["the u.s. drugs regulator said it was not recommending changes in the use of stimulants such as adderall xr and ritalin to treat hyperactivity, after a review of a study into potential heart disease risks from the drugs.", {}]]}}